These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34693105)

  • 21. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
    Yellapu NK; Pulaganti M; Pakala SB
    J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
    Chowdhury KH; Chowdhury MR; Mahmud S; Tareq AM; Hanif NB; Banu N; Reza ASMA; Emran TB; Simal-Gandara J
    Biology (Basel); 2020 Dec; 10(1):. PubMed ID: 33374717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
    Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
    J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
    Balkrishna A; Mittal R; Arya V
    Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach.
    Ajmal MR; Abdelhameed AS; Alam P; Khan RH
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Apr; 159():199-208. PubMed ID: 26851488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-Dimensional Screening Strategy for Drug Repurposing with Statistical Framework-A New Road to Influenza Drug discovery.
    Rohini K; Ramanathan K; Shanthi V
    Cell Biochem Biophys; 2019 Dec; 77(4):319-333. PubMed ID: 31559538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
    Ibrahim MAA; Abdelrahman AHM; Hassan AMA
    Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Search for Novel Lead Inhibitors of Yeast Cytochrome bc1, from Drugbank and COCONUT.
    Jović O; Šmuc T
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-Based Screening of DNA GyraseB Inhibitors for Therapeutic Applications in Tuberculosis: a Pharmacoinformatics Study.
    Tambe PM; Bhowmick S; Chaudhary SK; Khan MR; Wabaidur SM; Muddassir M; Patil PC; Islam MA
    Appl Biochem Biotechnol; 2020 Dec; 192(4):1107-1123. PubMed ID: 32686004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repurposing of FDA-approved drugs to target MurB and MurE enzymes in
    Rani J; Silla Y; Borah K; Ramachandran S; Bajpai U
    J Biomol Struct Dyn; 2020 Jun; 38(9):2521-2532. PubMed ID: 31244382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of 2-indolinone derivatives as PAK1 inhibitors in MDA-MB-231 cells.
    Yao D; Ruhan A; Jiang J; Huang J; Wang J; Han W
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127355. PubMed ID: 32738980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
    Arodola OA; Soliman ME
    Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
    Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
    BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors.
    Xie H; Li Y; Yu F; Xie X; Qiu K; Fu J
    Int J Mol Sci; 2015 Nov; 16(11):27350-61. PubMed ID: 26580609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-step molecular docking and dynamics simulation-based screening of large antiviral specific chemical libraries for identification of Nipah virus glycoprotein inhibitors.
    Kalbhor MS; Bhowmick S; Alanazi AM; Patil PC; Islam MA
    Biophys Chem; 2021 Mar; 270():106537. PubMed ID: 33450550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of 1H-indazole-3-carboxamide derivatives as potent and selective PAK1 inhibitors with anti-tumour migration and invasion activities.
    Zhang M; Fang X; Wang C; Hua Y; Huang C; Wang M; Zhu L; Wang Z; Gao Y; Zhang T; Liu H; Zhang Y; Lu S; Lu T; Chen Y; Li H
    Eur J Med Chem; 2020 Oct; 203():112517. PubMed ID: 32846314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational design of a PAK1 binding protein.
    Jha RK; Leaver-Fay A; Yin S; Wu Y; Butterfoss GL; Szyperski T; Dokholyan NV; Kuhlman B
    J Mol Biol; 2010 Jul; 400(2):257-70. PubMed ID: 20460129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational design of Tryprostatin-A derivatives as novel αβ-tubulin inhibitors.
    Fani N; Bordbar AK; Ghayeb Y; Sepehri S
    J Biomol Struct Dyn; 2015; 33(3):471-86. PubMed ID: 24606044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.